Ortho-Clinical Diagnostics Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Ortho-Clinical Diagnostics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7022
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ortho-Clinical Diagnostics Inc (OCD), a subsidiary of The Carlyle Group L.P., is a provider of in vitro diagnostic products and services. The company designs, develops, manufactures and distributes in-vitro diagnostic products. It serves clinical laboratories by providing comprehensive solutions for screening, diagnosing, monitoring and confirming diseases early. It also serves the global transfusion medicine community by offering donor screening and blood typing products. The company’s services include e-connectivity, customer service and support, Ortho Plus SM services, product training and consulting services. The company has manufacturing facilities in Rochester, New York, Pompano Beach, Florida and Wales and offers its products and services in North America, Latin America, Europe and Asia Pacific. Ortho-Clinical is headquartered in Raritan, New Jersey, the US.

Ortho-Clinical Diagnostics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ortho-Clinical Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Ortho-Clinical Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Ortho-Clinical Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Ortho-Clinical Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Ortho-Clinical Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Ortho-Clinical Diagnostics Inc, Medical Equipment, Deal Details 10
Private Equity 10
Carlyle Group Completes Acquisition of Ortho-Clinical Diagnostics from Johnson & Johnson for up to USD4 Billion 10
Gores Completes Acquisition Of Therakos From Ortho-Clinical Diagnostics 12
Partnerships 13
Ortho Clinical Diagnostics Enters into Distribution and Co-Promotion Agreement with Sentinel Diagnostics 13
Ortho Clinical Diagnostics Enters into Distribution and Co-Promotion Agreement with Thermo Fisher Scientific 14
Ortho-Clinical Diagnostics Enters into Agreement with Sphingotec 15
Ortho Clinical Diagnostics and EKF Diagnostic Enter into Agreement 16
Ortho Clinical Diagnostics Enters into Agreement with B·R·A·H·M·S 17
Wuhan Thalys Medical Tech Enters into Agreement with Ortho-Clinical Diagnostics 18
Ortho-Clinical Enters into Distribution Agreement with Quotient for MosaiQ 19
Astute Medical Expands its Co-Marketing Agreement with Ortho-Clinical Diagnostics 21
Sphere Medical Enters into Co-Development Agreement with Ortho-Clinical Diagnostics for Proxima 4 22
Ortho-Clinical Diagnostics Inc – Key Competitors 23
Ortho-Clinical Diagnostics Inc – Key Employees 24
Ortho-Clinical Diagnostics Inc – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 27
Financial Announcements 27
Jul 26, 2017: Ortho Clinical Diagnostics to Present 10 Scientific Posters, Seven Products at AACC 27
Corporate Communications 29
Jul 31, 2018: Ortho Clinical Diagnostics Achieves Distinguished No. 1 Ranking for Service Performance for 3rd Year in a Row 29
Legal and Regulatory 30
Jun 26, 2017: Ortho Clinical Diagnostics Receives FDA 510(k) Clearance for Ortho’s VITROS Insulin Reagent & Calibrators 30
Product News 31
Jun 01, 2018: ISBT Satellite Symposium Co-hosted by Ortho Clinical Diagnostics and Quotient Discusses Responding to the Challenges of Resource Constraints in Transfusion Diagnostics 31
May 08, 2018: Ortho Clinical Diagnostics Holds Summit to Help Asia-Pacific Lab Leaders Envision the Lab of the Future 32
Oct 02, 2017: Ortho Clinical Diagnostics to Present Data on Automation in Immunohematology and Demonstrate Its Entire Transfusion Medicine Portfolio at the 2017 AABB Annual Meeting 33
Jun 20, 2017: Quotient and Ortho Clinical Diagnostics to Present Symposium on Role of Extended Phenotyping in Blood Matching at ISBT 34
Jun 12, 2017: Ortho Clinical Diagnostics to Present Data on Early Detection Of Acute Kidney Injury Risk, Immunoassay Development at EUROMEDLAB Athens 2017 35
Apr 04, 2017: Ortho Clinical Diagnostics to Present Data on Early Detection Of Acute Kidney Injury, Total Lab Automation and Transfusion Medicine at MEDLAB Asia Pacific 2017 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Ortho-Clinical Diagnostics Inc, Medical Equipment, Key Facts 2
Ortho-Clinical Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Ortho-Clinical Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Ortho-Clinical Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Ortho-Clinical Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Ortho-Clinical Diagnostics Inc, Deals By Market, 2012 to YTD 2018 8
Ortho-Clinical Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Carlyle Group Completes Acquisition of Ortho-Clinical Diagnostics from Johnson & Johnson for up to USD4 Billion 10
Gores Completes Acquisition Of Therakos From Ortho-Clinical Diagnostics 12
Ortho Clinical Diagnostics Enters into Distribution and Co-Promotion Agreement with Sentinel Diagnostics 13
Ortho Clinical Diagnostics Enters into Distribution and Co-Promotion Agreement with Thermo Fisher Scientific 14
Ortho-Clinical Diagnostics Enters into Agreement with Sphingotec 15
Ortho Clinical Diagnostics and EKF Diagnostic Enter into Agreement 16
Ortho Clinical Diagnostics Enters into Agreement with B·R·A·H·M·S 17
Wuhan Thalys Medical Tech Enters into Agreement with Ortho-Clinical Diagnostics 18
Ortho-Clinical Enters into Distribution Agreement with Quotient for MosaiQ 19
Astute Medical Expands its Co-Marketing Agreement with Ortho-Clinical Diagnostics 21
Sphere Medical Enters into Co-Development Agreement with Ortho-Clinical Diagnostics for Proxima 4 22
Ortho-Clinical Diagnostics Inc, Key Competitors 23
Ortho-Clinical Diagnostics Inc, Key Employees 24
Ortho-Clinical Diagnostics Inc, Other Locations 25
Ortho-Clinical Diagnostics Inc, Subsidiaries 26

List of Figures
Ortho-Clinical Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Ortho-Clinical Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Ortho-Clinical Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Ortho-Clinical Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Ortho-Clinical Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Ortho-Clinical Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Ortho-Clinical Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Ortho-Clinical Diagnostics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Ortho-Clinical Diagnostics Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Chimerix Inc (CMRX):企業の財務・戦略的SWOT分析
    Summary Chimerix Inc (Chimerix) is a bio pharmaceutical company that develops, discovers, and commercializes novel and oral antiviral therapeutics. The company’s brincidofovir, an oral nucleotide analog to treat dsDNA viruses, adenovirus, cytomegalovirus, BK virus and herpes simplex viruses. Chimeri …
  • Coty Inc.:企業の戦略・SWOT・財務情報
    Coty Inc. - Strategy, SWOT and Corporate Finance Report Summary Coty Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Coherus BioSciences Inc (CHRS):企業の財務・戦略的SWOT分析
    Summary Coherus BioSciences Inc (Coherus) is a biosimilar platform company that develops and commercializes biosimilar drugs. The company’s pipeline product candidates include CHS-1701, an pegfilgrastim used to treat febrile neutropenia; CHS-0214, is an etanercept biosimilar candidate which is used …
  • Woodward Inc:戦略・SWOT・企業財務分析
    Woodward Inc - Strategy, SWOT and Corporate Finance Report Summary Woodward Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Kineta Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Kineta Inc (Kineta) is a biotech company that develops novel immuno-therapies. The company offers small-molecule compounds that target RIG-I-like receptor pathways and intracellular IRF3-inducing pathways for applications in cancer. Its KCP-400 is a novel non-opioid therapy for the treatment …
  • Sumitomo Mitsui Construction Co Ltd (1821):企業の財務・戦略的SWOT分析
    Sumitomo Mitsui Construction Co Ltd (1821) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Yourgene Health Plc (YGEN):企業の財務・戦略的SWOT分析
    Yourgene Health Plc (YGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • CDI Corp:企業の戦略的SWOT分析
    CDI Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Emerald Expositions, Inc. (EEX):企業の財務・戦略的SWOT分析
    Emerald Expositions, Inc. (EEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Gastar Exploration Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Gastar Exploration Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Gastar Exploration Inc (Gastar), formerly Gastar Exploration Ltd, is an energy company that offers exploration and development programs. The company explores, develops and produces natural gas …
  • Genetic Analysis AS:医療機器:M&Aディール及び事業提携情報
    Summary Genetic Analysis AS (Genetic Analysis) is a molecular diagnostic company that mapping of microbiota by utilizing the GA-map technology to develop IVD tests in various diseases. The company develops gene-based routine tests for the mapping and diagnosis of diseases related to dysbiosis and ba …
  • Callon Petroleum Co Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Callon Petroleum Co Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Callon Petroleum Co (CPC) is an oil and gas company that offers building reserves and production of onshore and offshore oil and natural gas. The company carries out acquisition, development, exp …
  • Cassa Depositi e Prestiti SpA:石油・ガス:M&Aディール及び事業提携情報
    Summary Cassa Depositi e Prestiti SpA (CDP) is a financial service provider that offers banking and financial services. The company offers loans to state and regional governments, public bodies, local authorities, and public-law entities through postal savings products under state guarantee and the …
  • Pampa Energia S.A (PAMP)-石油・ガス分野:企業M&A・提携分析
    Summary Pampa Energia S.A. (Pampa) is an integrated energy company. It generates, transmits and distributes electricity. The company produces electricity from thermal, hydro and wind sources. Pampa explores for and produces hydrocarbon products in Argentina, Ecuador and Venezuela; refines diesel, fu …
  • Spark Infrastructure Group:発電所・企業SWOT分析
    Spark Infrastructure Group - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …
  • The Gunma Bank Ltd:企業の戦略・SWOT・財務分析
    The Gunma Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Gunma Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • SR Technics Holding:企業の戦略的SWOT分析
    SR Technics Holding - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Ecclesiastical Insurance Office plc:戦略・SWOT・企業財務分析
    Ecclesiastical Insurance Office plc - Strategy, SWOT and Corporate Finance Report Summary Ecclesiastical Insurance Office plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • QuikTrip Corporation:企業の戦略的SWOT分析
    QuikTrip Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Delaware Municipal Electric Corporation, Inc.:企業の戦略的SWOT分析
    Delaware Municipal Electric Corporation, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆